Form D · Biotechnology
NEW AMSTERDAM SCIENCES, INC.
Scottsdale, AZ · CIK 0001656189
Offering snapshot reported Nov 19, 2015 · SEC filing
- Reported sold
- $250K Offering amount: $2M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Oct 6, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 19, 2015 | Initial | $250,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-251573
Source: Form D, filed Nov 19, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hal N. Siegel, Ph D. | Executive |
| Jerry Toepfer | Executive |
| Michael K. Wilhelm | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
14362 North Frank Lloyd Wright Blvd. Suite 1000
Scottsdale, AZ, 85260
Scottsdale, AZ, 85260